News

AddToAny

Google+ Facebook Twitter Twitter

IBMS contributes to Parliamentary pandemic report

Following the IBMS evidence submission and President Allan Wilson’s presentation to an All-Party Parliamentary Group (APPG) coronavirus inquiry, a parliamentary report has been published.

The biggest review to date of the UK’s response to coronavirus urges the government to adopt a “COVID-secure” exit strategy or risk a third spike in the New Year.

The IBMS has been listed as a key contributor in the cross-parliamentary new COVID-secure exit strategy, following the submission of evidence and Allan Wilson’s appearance at the APPG hearing last October.

The APPG was set up in July 2020 to conduct a rapid inquiry into the government’s handling of the pandemic.

Its purpose is to ensure that lessons are learned and to issue recommendations to the government “so that its preparedness and response may be improved in future”.

The report contains 71 key findings and makes 44 recommendations, which are termed “more important than ever”.

A key recommendation is the urgent need for a nationwide exit strategy, which acknowledges that by saving people’s lives, the UK, in turn, safeguards jobs and the economy.

It adds that the government needs to adopt the COVID-secure UK plan, to suppress the virus and then catch new cases at UK entry points, while the vaccine programmes are rolled out.  

The report and recommendations can be accessed by visiting bit.ly/36B4uqt

Image Credit | Shutterstock

Related Articles

Medical Science Laboratory with Diverse Multi-Ethnic Team of Microbiology Scientists Have Meeting on Developing Drugs, Medicine, Doing Biotechnology Research-CREDIT_istock-1293772951

Equity, diversity and inclusion for all

Jemma Shead, a Senior Biomedical Scientist at Synnovis and IBMS EDI Working Group member, on how and why you should get involved with EDI.

adeno associated virus capsid-Image Credit | Science Photo Library - c0142837

Examining the medical mystery of child hepatitis outbreak

A study has shed light on an unexpected wave of severe acute hepatitis cases in 2022, amid the backdrop of the ongoing global COVID-19 pandemic.

clostridioides difficile bacteria-Image Credit | Science Photo Library - c0016337

Faecal microbiota transplant for C. diff

In the first comprehensive US evidence-based guideline on the use of faecal microbiota-based therapies for gastrointestinal disease, the American Gastroenterological Association recommends faecal microbiota transplant (FMT) for most patients with recurrent Clostridioides difficile (C. diff) infection.

pseudomonas aeruginosa bacteria Image-Credit | Science Photo Library - f0381226

Tackling priority pathogen with phages

A new study describes the use of phage therapy to eradicate multidrug-resistant Pseudomonas aeruginosa infections in vivo with important new implications for antibiotic resistance.

Top